Pgp IHC staining with JSB-1 in breast cancer cells (arrow). (a) No
4.9 (278) · $ 8.00 · In stock
The multidrug resistance protein breast cancer resistance protein (BCRP) protects adipose-derived stem cells against ischemic damage
Cytoplasmic Confinement of Breast Cancer Resistance Protein (BCRP/ABCG2) as a Novel Mechanism of Adaptation to Short-Term Folate Deprivation
Targeted therapy for triple-negative breast cancer
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development
PDF) Association of P-glycoprotein expression and response to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
Filipus DASAWALA, General Surgeon, BMedSci MD, EKA Hospital, Serpong, Department of Surgery
PDF) Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development
Triple-negative breast cancer. (A) Representative images of
Cytoplasmic Confinement of Breast Cancer Resistance Protein (BCRP/ABCG2) as a Novel Mechanism of Adaptation to Short-Term Folate Deprivation
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
The multidrug resistance protein breast cancer resistance protein (BCRP) protects adipose-derived stem cells against ischemic damage
Does the Clearance of Inhaled 99mTc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung?
